We are committed to sharing data and are delighted to provide open access to summary information from PsoProtectMe. These data are preliminary and include a limited number of participants, so should not be used to inform clinical decision making.
We have recently published another scientific research paper detailing shielding behaviour, which can be found here. A summary of this research can also be found on the Psoriasis Association website here.
Summary data from PsoProtectMe’s first 3660 participants.
Participants per country (≥10 participants):
Average age: 46 years (range 3-91)
Average BMI: 26.8 kg/m2
Type of psoriasis: 3071 plaque psoriasis, 781 guttate psoriasis, 204 pustular psoriasis, 74 erythrodema
Coexisting psoriatic arthritis:
Type of psoriasis treatment:
Psoriasis severity change during the pandemic:
Have you been diagnosed with or thought you had COVID-19?
Did you go to hospital A&E due to your COVID-19?
Did you stay in hospital due to your COVID-19?
Has your COVID-19 infection got better?